1
|
Isolated IgG4-associated autoimmune hepatitis or the first manifestation of IgG4-related disease?
|
2023 Vol.22(4):415-417
|
|
Cosentino C, Clayton-Chubb D, McLean C, Roberts SK, Kemp W |
[Abstract]
(48)
[HTML 0 KB][PDF 0 KB]
(3344)
|
|
|
|
2
|
AGK2 pre-treatment protects against thioacetamide-induced acute liver failure via regulating the MFN2-PERK axis and ferroptosis signaling pathway
|
2024 Vol.23(1):43-51
|
|
Zhang QQ, Chen Q, Cao P, Shi CX, Zhang LY, Wang LW, Gong ZJ |
[Abstract]
(17)
[HTML 0 KB][PDF 0 KB]
(295)
|
|
|
|
3
|
Comment on “Robotic surgery and liver transplantation: A single-center experience of 501 robotic donor hepatectomies”
|
2024 Vol.23(1):109-110
|
|
Liu XY, Xu YY, Xiang Z, Zheng SS |
[Abstract]
(18)
[HTML 0 KB][PDF 0 KB]
(289)
|
|
|
|
4
|
Pancreatic panniculitis as the first presentation of pancreatic ductal adenocarcinoma
|
2024 Vol.23(1):106-108
|
|
Zhu WF, Fang S, Qiao JJ |
[Abstract]
(17)
[HTML 0 KB][PDF 0 KB]
(207)
|
|
|
|
5
|
Mechanism of hepatocytes differentiation and dedifferentiation in liver regeneration: Process and exploration
|
2023 Vol.22(4):331-332
|
|
He Z, Yang HY |
[Abstract]
(55)
[HTML 0 KB][PDF 0 KB]
(151)
|
|
|
|
6
|
Wnt/beta-catenin signaling and its modulators in nonalcoholic fatty liver diseases
|
2023 Vol.22(4):333-345
|
|
Shree Harini K, Ezhilarasan D |
[Abstract]
(75)
[HTML 0 KB][PDF 0 KB]
(135)
|
|
|
|
7
|
Radiomics in the diagnosis and treatment of hepatocellular carcinoma
|
2023 Vol.22(4):346-351
|
|
Jiang C, Cai YQ, Yang JJ, Ma CY, Chen JX, Huang L, Xiang Z, Wu J |
[Abstract]
(71)
[HTML 0 KB][PDF 0 KB]
(134)
|
|
|
|
8
|
Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma: A multicenter study
|
2023 Vol.22(6):594-604
|
|
Wang DD, Zhang JF, Zhang LH, Niu M, Jiang HJ, Jia FC, Feng ST |
[Abstract]
(29)
[HTML 0 KB][PDF 0 KB]
(124)
|
|
|
|
9
|
Low skeletal muscle mass and high visceral adiposity are associated with recurrence of acute cholecystitis after conservative management: A propensity score-matched cohort study
|
2024 Vol.23(1):64-70
|
|
Koya Y, Shibata M, Maruno Y, Sakamoto Y, Oe S, Miyagawa K, Honma Y, Harada M |
[Abstract]
(15)
[HTML 0 KB][PDF 0 KB]
(115)
|
|
|
|
10
|
Polyethylene glycol crosslinked decellularized single liver lobe scaffolds with vascular endothelial growth factor promotes angiogenesis in vivo
|
2023 Vol.22(6):622-631
|
|
Zhang JS, Wang ZB, Lai ZZ, Yang JW, Song WJ, Wei YB, Mei J, Wang JG |
[Abstract]
(17)
[HTML 0 KB][PDF 0 KB]
(107)
|
|
|
|
11
|
Recent advances in promising drugs for primary prevention of gastroesophageal variceal bleeding with cirrhotic portal hypertension
|
2024 Vol.23(1):4-13
|
|
Sheng JY, Meng ZF, Li Q, Yang YS |
[Abstract]
(21)
[HTML 0 KB][PDF 0 KB]
(107)
|
|
|
|
12
|
Interventional treatment options for management of delayed arterial hemorrhage after major hepato-pancreatic-biliary surgery
|
2023 Vol.22(6):648-649
|
|
Ielpo B, Alborino S, Melloul E, Salvatori F, Lai Q, Rossi M, Demartines N, Di Saverio S |
[Abstract]
(14)
[HTML 0 KB][PDF 0 KB]
(106)
|
|
|
|
13
|
A robust genomic-based prognostic model for the assessment of cancer stemness and survival for patients with hepatocellular carcinoma
|
2024 Vol.23(1):97-102
|
|
Du CL, Wei SY, Chen YH, Chen KJ |
[Abstract]
(16)
[HTML 0 KB][PDF 0 KB]
(106)
|
|
|
|
14
|
Development and validation of machine learning models for nonalcoholic fatty liver disease
|
2023 Vol.22(6):615-621
|
|
Peng HY, Duan SJ, Pan L, Wang MY, Chen JL, Wang YC, Yao SK |
[Abstract]
(15)
[HTML 0 KB][PDF 0 KB]
(105)
|
|
|
|
15
|
Endoscopic hemostasis using self-expandable metal stent combined with PuraStatR for patient with high risk of post-endoscopic sphincterotomy bleeding (with video)
|
2024 Vol.23(1):94-96
|
|
Ogura T, Uba Y, Yamamura M, Nishioka N, Nishikawa H |
[Abstract]
(12)
[HTML 0 KB][PDF 0 KB]
(104)
|
|
|
|
16
|
Post-fontan circulation hepatocellular carcinoma: Open and laparoscopic hepatectomy
|
2024 Vol.23(1):90-93
|
|
Ho KKY, She WH, Tsang SHY, Lo KS, Cheung TT |
[Abstract]
(20)
[HTML 0 KB][PDF 0 KB]
(104)
|
|
|
|
17
|
A new prognostic model for drug-induced liver injury especially suitable for Chinese population
|
2023 Vol.22(6):551-553
|
|
Chen YF, Li LJ |
[Abstract]
(20)
[HTML 0 KB][PDF 0 KB]
(92)
|
|
|
|
18
|
Pre-MASLD: Should it be defined separately?
|
2024 Vol.23(1):1-3
|
|
Huang HK, Li YM, Xu CF |
[Abstract]
(25)
[HTML 0 KB][PDF 0 KB]
(80)
|
|
|
|
19
|
Thanks
|
2023 Vol.22(6):661-A9
|
|
|
[Abstract]
(28)
[HTML 0 KB][PDF 43 KB]
(75)
|
|
|
|
20
|
Prognostic implication of early posttransplant hypercholesterolemia in liver transplantation for patients with hepatocellular carcinoma
|
2023 Vol.22(3):228-238
|
|
Wei RL, Fan GH, Zhang CZ, Chen KC, Zhang WH, Li CB, Dong SY, Chen JL, Ling SB, Zheng SS, Xu X |
[Abstract]
(84)
[HTML 0 KB][PDF 0 KB]
(75)
|
|
|
|